ABOUT THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.

BioProduction Division

With a proven portfolio of solutions that span discovery through large-scale commercial production, we bring process intensification across your upstream and downstream workflows, without compromising on quality. And to stay ahead of future bioprocessing needs, we are focused on working with customers and utilizing our unique capabilities, like open architecture engineering and customization, to provide the right solutions to achieve optimal bioprocessing outcomes. That’s our commitment to you and it’s what we call Bioprocessing by Design.

WEBINARS AND VIDEOS

  • 1_20C2B556099B9850F3EE2B6F19A64365
    Enabling GMP Production with Enhanced Single-Use Fermentors

    As more products are moved into single use fermenters, there is greater need to improved oxygen delivery closer to or beyond the abilities of stainless-steel vessels.

  • 1_E4230FE18AC53E3EB10BF0F75476EA06
    A Collaborative Path To Single-Use Supply Assurance

    Learn how leading biopharma companies such as Sanofi and single-use solutions provider Thermo Fisher Scientific are addressing supply challenges and developing collaborative processes. 

  • 1_797E2FE2ECF9A8CD8C8F91ECC0319FFB
    Accelerating Progress: Key Considerations For CDMOs To Maximize Productivity And Scalability

    Due to the urgent demand for vaccines and treatments, the biopharmaceutical industry is experiencing disruptive changes and increased demand on resources that are requiring a significant operational transformation. To accelerate the delivery of life-saving therapeutics, it is essential to evaluate effective ways to maximize efficiencies and increase capacity while minimizing risk. Flexibility is critical in bioprocessing today to stay up to speed with the quickly shifting needs of the industry.

  • Thermo
    Single-Use Technologies In The Battle Against SARS-CoV-2

    The Single-Use Technologies (SUT) business at Thermo Fisher Scientific is helping our customers in their fight against SARS-CoV-2 by providing assurance of supply. This video discusses our escalation routes through the Coronavirus Command Centre, our SUT capacity expansions and contains a customer testimonial from AGC Biologics.

  • 1_30440A151C682152B34F6FF2C9FC08FB
    Accelerating Delivery In The Next Stage Of The SARS-CoV-2 Battle

    What does pressure to address critical challenges of speed, scale, and supply mean for technologies enabling production, and how does it impact the future of vaccine and biotherapeutic manufacturing?

CONTACT INFORMATION

Thermo Fisher Scientific

7305 Executive Way

Frederick, MD 21704

UNITED STATES

Contact: Deirdre Reardon

HOT PRODUCTS

FEATURED ARTICLES